Literature DB >> 25525943

Bath salts in the emergency department: a survey of emergency clinicians' experience with bath salts-intoxicated patients.

Mohsen Vazirian1, Jason M Jerry, Jeffrey James, Roman M Dale.   

Abstract

OBJECTIVES: Several novel synthetic amphetamines have been marketed worldwide as "bath salts." The use of bath salts is associated with severe medical consequences resulting in a US federal ban over the last 3 years on the more common substances found in this group. Bath salts intoxication has a relatively nonspecific presentation, and urine toxicology confirmation in emergency departments (EDs) is impractical because the turnaround time is several days. Emergency clinicians must therefore rely heavily on patients' self-reports to verify the diagnosis. We performed an online survey of emergency clinicians to determine their degree of exposure to bath salts-intoxicated patients, the clinically relevant features of such patients, and the typical emergency management.
METHODS: We invited 124 physicians and physician assistants in 7 Cleveland Clinic EDs to participate in an online survey.
RESULTS: From a total of 43 of the 124 respondents, 77% did not specifically ask patients about bath salts use. Sixty percent had encountered a bath salts-intoxicated individual. Most respondents reported that the majority of patients were male, were between 19 and 29 years old, and used other drugs in addition to bath salts. Agitation, aggression/violence, and hallucinations were reported to be the most common presentations, and intravenous/intramuscular tranquilization was reported as the most often used management. Most patients were discharged home from the ED.
CONCLUSIONS: Despite the lack of toxicology screening in EDs, about two thirds of the surveyed emergency clinicians encountered bath salts-intoxicated individuals. Our study demonstrates the need for increased screening of bath salts intoxication in EDs, especially in agitated patients.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25525943     DOI: 10.1097/ADM.0000000000000094

Source DB:  PubMed          Journal:  J Addict Med        ISSN: 1932-0620            Impact factor:   3.702


  7 in total

1.  Correlates of new psychoactive substance use among a self-selected sample of nightclub attendees in the United States.

Authors:  Joseph J Palamar; Monica J Barratt; Jason A Ferris; Adam R Winstock
Journal:  Am J Addict       Date:  2016-07-15

2.  Self-reported use of novel psychoactive substances in a US nationally representative survey: Prevalence, correlates, and a call for new survey methods to prevent underreporting.

Authors:  Joseph J Palamar; Silvia S Martins; Mark K Su; Danielle C Ompad
Journal:  Drug Alcohol Depend       Date:  2015-09-03       Impact factor: 4.492

3.  "Ecstasy" to addiction: Mechanisms and reinforcing effects of three synthetic cathinone analogs of MDMA.

Authors:  Sean B Dolan; Zhenglan Chen; Renqi Huang; Michael B Gatch
Journal:  Neuropharmacology       Date:  2018-01-31       Impact factor: 5.250

Review 4.  Synthetic cathinone adulteration of illegal drugs.

Authors:  Chicora F Oliver; Joseph J Palamar; Alberto Salomone; Steven J Simmons; Helene L Philogene-Khalid; Nick Stokes-McCloskey; Scott M Rawls
Journal:  Psychopharmacology (Berl)       Date:  2018-10-18       Impact factor: 4.530

Review 5.  Emergency Medicine Research Priorities for Early Intervention for Substance Use Disorders.

Authors:  Kathryn F Hawk; Rachel L Glick; Arthur R Jey; Sydney Gaylor; Jamie Doucet; Michael P Wilson; John S Rozel
Journal:  West J Emerg Med       Date:  2019-02-19

6.  Designer Drugs: A Synthetic Catastrophe.

Authors:  James Fratantonio; Lawrence Andrade; Marcelo Febo
Journal:  J Reward Defic Syndr       Date:  2015-08-10

7.  The Chameleon-Like Properties of Psychoactive Drugs: Examinations with HR LC-MS/MS Technology of Patients Presenting at the Emergency Department Following the Use of Synthetic Cannabinoids: A Case Series and Literature Review.

Authors:  Ismail Altintop; Cigdem Karakukcu
Journal:  Behav Sci (Basel)       Date:  2018-09-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.